Clinical trials
Phase 2 Cardiovascular Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 7 |
| Cardurion Pharmaceuticals, Inc. | 3 |
| Akcea Therapeutics | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Manitoba | 2 |
| Alnylam Pharmaceuticals | 1 |
| Amgen | 1 |
| Canadian Myeloma Research Group | 1 |
| Dr. Amer Johri | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 25 |
| Heart Diseases | 7 |
| Hyperlipidemias | 7 |
| Hypercholesterolemia | 4 |
| Atherosclerosis | 3 |
| Dyslipidemias | 3 |
| Heart Failure | 3 |
| Vascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.